HAEGT

HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
HAEGT(CAS 852155-81-8)

CAT No: R1406

CAS No:852155-81-8

Synonyms/Alias:HAEGT;852155-81-8;CJB15581;HY-P1230;CS-8147;DA-64003;MS-29530;G16224;(4S)-4-[(2S)-2-[(2S)-2-Amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)c arbamoyl]butanoic acid;(4S)-4-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-[[2-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C20H31N7O9
M.W/Mr.
513.5
Sequence
One Letter Code:HAEGT
Three Letter Code:H-His-Ala-Glu-Gly-Thr-OH

HAEGT is a synthetic peptide compound composed of the amino acid sequence Histidine-Alanine-Glutamic acid-Glycine-Threonine. As a short, well-defined peptide, it serves as a valuable tool in biochemical and molecular biology research, where precise sequence motifs are critical for understanding structure-function relationships. Its defined sequence lends itself to investigations in peptide-based assay development, receptor-ligand interaction studies, and as a model substrate in enzymatic research. The chemical and structural properties of HAEGT make it relevant for a wide range of experimental applications that require high specificity and reproducibility, supporting the advancement of peptide science in both fundamental and applied settings.

Peptide synthesis validation: HAEGT is frequently utilized as a model sequence for optimizing and validating solid-phase peptide synthesis (SPPS) protocols. Its moderate length and diverse side-chain functionalities provide a practical challenge for assessing coupling efficiency, deprotection strategies, and overall synthetic yield. Researchers employ this peptide to benchmark new synthesis reagents or methodologies, ensuring robust and reproducible peptide production prior to scaling up more complex or costly targets.

Enzymatic substrate studies: The defined sequence of this pentapeptide makes it an excellent candidate for use as a substrate in enzymatic assays, particularly for proteases or peptidases that recognize specific sequence motifs. By monitoring the cleavage or modification of HAEGT, scientists can characterize enzyme specificity, kinetics, and inhibition profiles. This approach is instrumental in elucidating proteolytic mechanisms and screening for enzyme modulators in drug discovery and basic research.

Protein interaction analysis: HAEGT can be employed as a probe in studies aimed at mapping protein-peptide interactions. Its unique sequence may mimic recognition motifs found in larger proteins, allowing researchers to dissect binding affinities, map interaction surfaces, or screen for competitive inhibitors. The use of such synthetic peptides in binding assays, surface plasmon resonance, or pull-down experiments provides detailed insight into molecular recognition events central to cell signaling and regulatory pathways.

Analytical method development: In the context of analytical chemistry, this peptide serves as a reference or calibration standard for techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Its well-characterized mass and retention properties assist in method validation, instrument calibration, and troubleshooting of analytical workflows. The reproducibility and stability of HAEGT enable accurate assessment of system performance, supporting reliable quantitation and identification of peptides in complex mixtures.

Peptide structure-function studies: The sequence-specific nature of HAEGT allows for its use in systematic investigations of peptide conformation and biological activity. Researchers can utilize it to explore the effects of sequence variation on secondary structure formation, stability, or bioactivity, using spectroscopic or computational approaches. Such studies contribute to a deeper understanding of the principles governing peptide folding, aggregation, and function, which are fundamental to the design of novel biomolecules and therapeutic candidates.

InChI
InChI=1S/C20H31N7O9/c1-9(25-18(33)12(21)5-11-6-22-8-24-11)17(32)26-13(3-4-15(30)31)19(34)23-7-14(29)27-16(10(2)28)20(35)36/h6,8-10,12-13,16,28H,3-5,7,21H2,1-2H3,(H,22,24)(H,23,34)(H,25,33)(H,26,32)(H,27,29)(H,30,31)(H,35,36)/t9-,10+,12-,13-,16-/m0/s1
InChI Key
LUWRDKLVTXFZFK-AWCHJOLGSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Analysis ServicesCustom Conjugation ServiceEpitope Mapping ServicesPeptide CDMOPeptide Synthesis ServicesPeptide Nucleic Acids SynthesisPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers